| Primary |
| Drug Use For Unknown Indication |
50.0% |
| Depression |
25.0% |
| Insomnia |
25.0% |
|
| Pneumonia |
33.3% |
| Tachycardia |
33.3% |
| Therapeutic Product Ineffective |
33.3% |
|
| Secondary |
| Depression |
20.8% |
| Drug Use For Unknown Indication |
19.1% |
| Product Used For Unknown Indication |
12.7% |
| Hypertension |
8.4% |
| Intentional Overdose |
5.5% |
| Muscle Spasticity |
4.0% |
| Suicide Attempt |
3.8% |
| Anxiety Disorder |
2.6% |
| Pain |
2.3% |
| Sleep Disorder |
2.3% |
| Tremor |
2.3% |
| Borderline Personality Disorder |
2.0% |
| Post-traumatic Stress Disorder |
2.0% |
| Sepsis |
2.0% |
| Tachyarrhythmia |
2.0% |
| Foetal Exposure During Pregnancy |
1.7% |
| Prophylaxis Of Neural Tube Defect |
1.7% |
| Type 2 Diabetes Mellitus |
1.7% |
| Diabetes Mellitus |
1.4% |
| Hyperuricaemia |
1.4% |
|
| Suicide Attempt |
18.7% |
| Tachycardia |
13.2% |
| Hyponatraemia |
7.7% |
| Intentional Overdose |
6.6% |
| Patent Ductus Arteriosus |
5.5% |
| Suicidal Ideation |
5.5% |
| Vomiting |
5.5% |
| White Blood Cell Count Increased |
5.5% |
| Abortion Spontaneous |
3.3% |
| Electrocardiogram Qt Prolonged |
3.3% |
| Neonatal Respiratory Distress Syndrome |
3.3% |
| Serotonin Syndrome |
3.3% |
| Weight Decreased |
3.3% |
| Cholelithiasis |
2.2% |
| Congenital Tricuspid Valve Incompetence |
2.2% |
| Delirium |
2.2% |
| Drug Toxicity |
2.2% |
| Foetal Exposure During Pregnancy |
2.2% |
| Gamma-glutamyltransferase Increased |
2.2% |
| Mechanical Ventilation |
2.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
22.6% |
| Drug Use For Unknown Indication |
22.0% |
| Depression |
9.7% |
| Hiv Infection |
8.9% |
| Hypertension |
7.9% |
| Epilepsy |
3.1% |
| Prophylaxis |
3.0% |
| Sleep Disorder |
2.5% |
| Malignant Lymphoid Neoplasm |
2.3% |
| Diabetes Mellitus |
2.1% |
| Rheumatoid Arthritis |
2.1% |
| Head And Neck Cancer |
1.9% |
| Hypothyroidism |
1.8% |
| Multiple Sclerosis |
1.8% |
| Asthma |
1.7% |
| Breast Cancer |
1.4% |
| Pain |
1.4% |
| Constipation |
1.3% |
| Anxiety |
1.2% |
| Cardiac Failure |
1.2% |
|
| Bundle Branch Block Right |
8.3% |
| Pyrexia |
7.1% |
| Suicide Attempt |
7.1% |
| Weight Increased |
7.1% |
| Completed Suicide |
6.0% |
| Hyponatraemia |
6.0% |
| Hypotension |
4.8% |
| Rectal Haemorrhage |
4.8% |
| Renal Failure |
4.8% |
| Skin Discolouration |
4.8% |
| Somnolence |
4.8% |
| Weight Decreased |
4.8% |
| Withdrawal Syndrome |
4.8% |
| Depression |
3.6% |
| Eczema |
3.6% |
| Gastrointestinal Disorder Postoperative |
3.6% |
| Nightmare |
3.6% |
| Sudden Onset Of Sleep |
3.6% |
| Syncope |
3.6% |
| Thrombophlebitis Superficial |
3.6% |
|
| Interacting |
| Hypertension |
22.2% |
| Hypertensive Heart Disease |
22.2% |
| Depression |
16.7% |
| Diuretic Therapy |
11.1% |
| Atrial Fibrillation |
5.6% |
| Insomnia |
5.6% |
| Ischaemic Heart Disease Prophylaxis |
5.6% |
| Nervousness |
5.6% |
| Osteoporosis Prophylaxis |
5.6% |
|
| Drug Interaction |
75.0% |
| Cholangitis |
8.3% |
| Leukocytosis |
8.3% |
| Therapeutic Agent Toxicity |
8.3% |
|
